<!DOCTYPE html>

<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>Model</title>
    <link rel="stylesheet" href="css/reset.css">
    <link rel="stylesheet" href="css/fonts.css">
    <link rel="stylesheet" href="css/page.css">
    <link rel="stylesheet" href="css/header.css">
    <link rel="stylesheet" href="css/main-section.css">
    <link rel="stylesheet" href="css/info-card.css">
    <link rel="stylesheet" href="css/footer.css">
  </head>

  <body class="page"> 
    <div class="page__content">
      <header class="header">
        <div class="menu">
          <div class="menu__icon">
            <div class="menu__line"></div>
            <div class="menu__line"></div>
            <div class="menu__line"></div>
          </div>
        </div>  
        
        <div class="header__central-block">
          <div class="select select--top-2">
            <span class="select__label">Current scenario:</span>
            <span class="select__value">Base case</span>
            <div class="select__drop-icon">
              <div class="select__arrow"></div>
              <div class="select__arrow select__arrow--down"></div>
            </div>
          </div>
          
          <div class="select">
            <img  class="select__icon" src="images/user.svg" alt="user icon">
              
            <span class="select__value select__value--larger">200</span>
            
            <div class="select__drop-icon">
              <div class="select__arrow select__arrow--larger"></div>
              <div class="select__arrow select__arrow--larger select__arrow--down"></div>
            </div>
          </div>
        </div>

        <div class="info">
          <img class="info__icon" src="images/info.svg" alt="info icon">
        </div>
      </header>
    
      <main class="main-section">
        <div class="main-section__header">
          <h1 class="main-section__heading">Key assumptions</h1>
        </div>
        
        <div class="main-section__body">
          <div class="main-section__column">
            <div class="info-card info-card--key-assumptions">
              <div class="info-card__header">
                <div class="info-card__heading">Epidemology</div>
              </div>
              <div class="info-card__body">
                <div class="info-card__circle-chart">
                  <img class="info-card__circle-icon" src="images/circle-chart.svg" alt="circle-chart"></img>
                  <div class="info-card__circle-value">72%</div>
                </div>
                <div class="info-card__lead">72% of all HCC cases are eligible for treatment with Y90. </div>
                <div class="info-card__paragraph info-card__paragraph--fs-small"> Eligibility is based on the BCLC staging system and includes patients in early stage bridging to transplant, intermediate stage, 
                  and advanced stages with and without portal vein thrombosis</div>
              </div>
            </div>
            <div class="info-card info-card--key-assumptions">
              <div class="info-card__header">
                <div class="info-card__heading">Y90 uptake</div>
              </div>
              <div class="info-card__body">
                <div class="info-card__circle-chart">
                  <img class="info-card__circle-icon" src="images/circle-chart.svg" alt="circle-chart"></img>
                  <div class="info-card__circle-value">34%</div>
                </div>
                <div class="info-card__lead">34% of eligible patients would be treated with TheraSphere</div>
                <div class="info-card__paragraph info-card__paragraph--fs-small"> The uptake of Y90 treatment in eligible patients is assumed to be progressive and specific to each HCC stage. On average, 
                  34% of eligible patients would be treated with TheraSphere instead of the current standard of care per year</div>
              </div>
            </div>
            <div class="info-card info-card--key-assumptions info-card--key-assumptions-horizontal">
              <div class="info-card__header info-card__header--costs-category">
                <div class="info-card__heading">Desease management</div>
              </div>
              <div class="info-card__body">
                <div class="info-card__lead">Average number of treatments <br>per patient:</div>
              </div>
              <div class="hrz-graph">
                <div class="hrz-graph__row">
                  <div class="hrz-graph__label">Y90</div>
                  <div class="hrz-graph__line"></div>
                  <div class="hrz-graph__value">1.4</div>
                </div>
                <div class="hrz-graph__row">
                  <div class="hrz-graph__label">TACE</div>
                  <div class="hrz-graph__line"></div>
                  <div class="hrz-graph__value">2.8</div>
                </div>
              </div>
              <p class="info-card__paragraph info-card__paragraph--fs-small">TACE is composed of 69% cTACE and 31% DEB-TACE4, and performed on
 average 2.9 times per patient6,7, as opposed to 1.4 treatments for Y90</p>
            </div>
          </div>
          <div class="main-section__divider">
            <div class="main-section__divider-line"></div>
          </div>
          <div class="main-section__column">
            <div class="info-card info-card--key-assumptions-costs">
              <div class="info-card__header info-card__header--costs-category">
                <h3 class="info-card__subheading">Category 1</h3>
                <h2 class="info-card__heading">Drug and device <br>acquisition cost</h2>
              </div>
              <div class="info-card__body">
                <p class="info-card__paragraph info-card__paragraph--fs-small">While the acquisition of Y90 is completely covered by 
                  reimbursement, TACE costs $7,200 per patient for drugs and device acquisition</p>
              </div>
              <div class="info-card__costs">
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">Y90</div>
                  <div class="info-card__costs-value info-card__costs-value--reimbursed">Reimbursed</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">TACE</div>
                  <div class="info-card__costs-value">$7200</div>
                </div>
              </div>
            </div>
            <div class="info-card info-card--key-assumptions-costs">
              <div class="info-card__header info-card__header--costs-category">
                <h3 class="info-card__subheading">Category 2</h3>
                <h2 class="info-card__heading">Administration cost</h2>
              </div>
              <div class="info-card__body">
                <p class="info-card__paragraph info-card__paragraph--fs-small">Administration costs $5,903 per patient treated with 
                  Y90 and $8,297 per patient treated with TACE. This includes procedures of liver imaging, 
                  angiograms, coil embolization, salaries of nurse and nuclear safety officer, 
                  and hospital admission of 6 hours for Y90 and 1 day for TACE</p>
              </div>
              <div class="info-card__costs">
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">Y90</div>
                  <div class="info-card__costs-value">$5.9K</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">TACE</div>
                  <div class="info-card__costs-value">$8.3K</div>
                </div>
              </div>
            </div>
            <div class="info-card info-card--key-assumptions-costs">
              <div class="info-card__header info-card__header--costs-category">
                <h3 class="info-card__subheading">Category 3</h3>
                <h2 class="info-card__heading">Adverse event <br>management cost</h2>
              </div>
              <div class="info-card__body">
                <p class="info-card__paragraph info-card__paragraph--fs-small">Managing adverse events cost $1,017 for Y90, 
                  $2,560 for TACE and $6,746 for sorafenib</p>
              </div>
              <div class="info-card__costs">
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">Y90</div>
                  <div class="info-card__costs-value">$1.0K</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">TACE</div>
                  <div class="info-card__costs-value">$3.6K</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">sorafenib</div>
                  <div class="info-card__costs-value">-$6.4K</div>
                </div>
              </div>
            </div>
            <div class="info-card info-card--key-assumptions-costs">
              <div class="info-card__header info-card__header--costs-category">
                <h3 class="info-card__subheading">Category 4</h3>
                <h2 class="info-card__heading">Reimbursement</h2>
              </div>
              <div class="info-card__body">
                <p class="info-card__paragraph info-card__paragraph--fs-small">Reimbursement is obtained for Y90 acquisition, 
                  procedures and management of adverse events. Reimbursement totals $44,085 per patient 
                  treated with Y90, $32,574 per TACE  patient and $6,434 per sorafenib patient</p>
              </div>
              <div class="info-card__costs">
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">Y90</div>
                  <div class="info-card__costs-value">-$47.8K</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">TACE</div>
                  <div class="info-card__costs-value">-$35,3</div>
                </div>
                <div class="info-card__costs-line">
                  <div class="info-card__costs-label">sorafenib</div>
                  <div class="info-card__costs-value">-$6.4K</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </main>



      <footer class="footer">
        <div class="footer__content-container">
          <span class="footer__copyright">Â© 2016 BTG International Canada Inc.</span>
        
          <div class="footer__pages-indicator">
            <img class="footer__pages-icon" src="images/pagination-icon.svg" alt="pagination icon">
            <div class="footer__pages-counter">
              <span class="footer__page-num">1</span>/<span class="footer__of-pages">10</span>
            </div>
          </div>
        </div>
          
          
        <div class="footer__page-nav">
          <button class="footer__button" type="button">
            <img class="footer__button-arrow footer__button-arrow_left" src="images/arrow.svg" alt="arrow">
          </button>
          <button class="footer__button" type="button">
            <img class="footer__button-arrow" src="images/arrow.svg" alt="arrow">
          </button>              
        </div>
      </footer>
    </div>
  </body>
</html>